Author:
Linger R M A,Cohen R A,Cummings C T,Sather S,Migdall-Wilson J,Middleton D H G,Lu X,Barón A E,Franklin W A,Merrick D T,Jedlicka P,DeRyckere D,Heasley L E,Graham D K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference65 articles.
1. Society AC . Cancer Facts & Figures 2012. American Cancer Society, Atlanta, 2012.
2. SEER Cancer Statistics Review, 1975–2008 [database on the Internet] National Cancer Institute, 2011 [cited 1/25/2012]. Available from:
http://seer.cancer.gov/csr/1975_2008/
.
3. Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 2011; 12: 1004–1012.
4. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947–957.
5. Paik PK, Arcila ME, Fara M, Sima CS, Miller VA, Kris MG et al. Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 2011; 29: 2046–2051.
Cited by
171 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献